25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biomerica Inc
Buy, Hold or Sell?

Let's analyze Biomerica together

I guess you are interested in Biomerica Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biomerica Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biomerica Inc

I send you an email if I find something interesting about Biomerica Inc.

1. Quick Overview

1.1. Quick analysis of Biomerica (30 sec.)










1.2. What can you expect buying and holding a share of Biomerica? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.32
Expected worth in 1 year
$0.00
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$-0.32
Return On Investment
-102.7%

For what price can you sell your share?

Current Price per Share
$0.31
Expected price per share
$0.2688 - $0.5
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biomerica (5 min.)




Live pricePrice per Share (EOD)
$0.31
Intrinsic Value Per Share
$-5.66 - $-2.94
Total Value Per Share
$-5.34 - $-2.62

2.2. Growth of Biomerica (5 min.)




Is Biomerica growing?

Current yearPrevious yearGrowGrow %
How rich?$5.3m$8.9m-$1.6m-22.6%

How much money is Biomerica making?

Current yearPrevious yearGrowGrow %
Making money-$1.5m-$1.5m$9.5k0.6%
Net Profit Margin-121.2%-121.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Biomerica (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#252 / 320

Most Revenue
#247 / 320

Most Profit
#162 / 320

Most Efficient
#244 / 320
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biomerica?

Welcome investor! Biomerica's management wants to use your money to grow the business. In return you get a share of Biomerica.

First you should know what it really means to hold a share of Biomerica. And how you can make/lose money.

Speculation

The Price per Share of Biomerica is $0.3138. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biomerica.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biomerica, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.32. Based on the TTM, the Book Value Change Per Share is $-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biomerica.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.08-24.9%-0.09-29.2%-0.09-29.4%-0.08-25.8%-0.05-16.4%
Usd Book Value Change Per Share-0.07-23.6%-0.08-25.7%0.0411.6%0.011.6%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.07-23.6%-0.08-25.7%0.0411.6%0.011.6%0.00-0.2%
Usd Price Per Share0.44-0.79-2.21-3.45-2.87-
Price to Earnings Ratio-1.41--2.10--5.96--20.58--29.99-
Price-to-Total Gains Ratio-5.94--9.57--27.23--951.15--586.47-
Price to Book Ratio1.38-1.79-4.91-6.78-7.78-
Price-to-Total Gains Ratio-5.94--9.57--27.23--951.15--586.47-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.3138
Number of shares3186
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.080.01
Usd Total Gains Per Share-0.080.01
Gains per Quarter (3186 shares)-256.7316.31
Gains per Year (3186 shares)-1,026.9265.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1027-103706555
20-2054-20640130120
30-3081-30910196185
40-4108-41180261250
50-5135-51450326315
60-6162-61720391380
70-7188-71990457445
80-8215-82260522510
90-9242-92530587575
100-10269-102800652640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%52.079.09.037.1%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%5.015.00.025.0%9.031.00.022.5%62.061.017.044.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%2.00.038.05.0%2.00.0138.01.4%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%5.015.00.025.0%9.031.00.022.5%62.061.017.044.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biomerica Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.074-0.081+9%0.036-304%0.005-1546%-0.001-99%
Book Value Per Share--0.3180.433-27%0.531-40%0.520-39%0.400-21%
Current Ratio--2.9964.145-28%5.612-47%5.193-42%6.062-51%
Debt To Asset Ratio--0.3210.265+21%0.229+40%0.278+15%0.211+52%
Debt To Equity Ratio--0.4720.365+29%0.300+57%0.414+14%0.300+57%
Dividend Per Share----0%-0%-0%0.000-100%
Enterprise Value--7697524.24015652177.702-51%41145969.725-81%60493460.387-87%49704730.129-85%
Eps---0.078-0.092+17%-0.092+18%-0.081+4%-0.052-34%
Ev To Ebitda Ratio---1.514-2.515+66%-6.763+347%-105.829+6890%-80.949+5246%
Ev To Sales Ratio--1.0653.141-66%7.869-86%8.904-88%8.091-87%
Free Cash Flow Per Share---0.080-0.076-5%-0.084+6%-0.068-15%-0.042-47%
Free Cash Flow To Equity Per Share---0.080-0.076-5%0.028-389%0.006-1392%0.003-2474%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.941--------
Intrinsic Value_10Y_min---5.658--------
Intrinsic Value_1Y_max---0.187--------
Intrinsic Value_1Y_min---0.312--------
Intrinsic Value_3Y_max---0.645--------
Intrinsic Value_3Y_min---1.165--------
Intrinsic Value_5Y_max---1.201--------
Intrinsic Value_5Y_min---2.258--------
Market Cap5278618.080-40%7401524.24013333677.702-44%37133712.475-80%58030327.987-87%48318580.804-85%
Net Profit Margin---0.728-1.212+66%-1.215+67%-0.922+27%-0.595-18%
Operating Margin---0.757-1.254+66%-1.246+65%-0.937+24%-0.594-22%
Operating Ratio--1.7572.280-23%2.246-22%1.946-10%1.601+10%
Pb Ratio0.987-40%1.3841.790-23%4.909-72%6.780-80%7.783-82%
Pe Ratio-1.003+29%-1.406-2.099+49%-5.963+324%-20.581+1364%-29.992+2033%
Price Per Share0.314-40%0.4400.793-44%2.208-80%3.450-87%2.872-85%
Price To Free Cash Flow Ratio-0.982+29%-1.377-2.767+101%-6.846+397%-569.090+41235%-314.588+22750%
Price To Total Gains Ratio-4.240+29%-5.945-9.574+61%-27.228+358%-951.145+15899%-586.468+9765%
Quick Ratio--2.0323.023-33%4.264-52%3.612-44%3.535-43%
Return On Assets---0.167-0.158-5%-0.144-14%-0.122-27%-0.093-44%
Return On Equity---0.246-0.217-12%-0.190-23%-0.168-32%-0.123-50%
Total Gains Per Share---0.074-0.081+9%0.036-304%0.005-1546%0.000-99%
Usd Book Value--5346000.0007282000.000-27%8930252.750-40%8739175.000-39%6724823.375-21%
Usd Book Value Change Per Share---0.074-0.081+9%0.036-304%0.005-1546%-0.001-99%
Usd Book Value Per Share--0.3180.433-27%0.531-40%0.520-39%0.400-21%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Enterprise Value--7697524.24015652177.702-51%41145969.725-81%60493460.387-87%49704730.129-85%
Usd Eps---0.078-0.092+17%-0.092+18%-0.081+4%-0.052-34%
Usd Free Cash Flow---1344000.000-1270750.000-5%-1420515.750+6%-1148209.950-15%-709984.600-47%
Usd Free Cash Flow Per Share---0.080-0.076-5%-0.084+6%-0.068-15%-0.042-47%
Usd Free Cash Flow To Equity Per Share---0.080-0.076-5%0.028-389%0.006-1392%0.003-2474%
Usd Market Cap5278618.080-40%7401524.24013333677.702-44%37133712.475-80%58030327.987-87%48318580.804-85%
Usd Price Per Share0.314-40%0.4400.793-44%2.208-80%3.450-87%2.872-85%
Usd Profit---1316000.000-1540500.000+17%-1550031.000+18%-1363341.900+4%-853805.550-35%
Usd Revenue--1807000.0001376749.750+31%1353641.250+33%2206386.550-18%1773660.475+2%
Usd Total Gains Per Share---0.074-0.081+9%0.036-304%0.005-1546%0.000-99%
 EOD+3 -5MRQTTM+15 -22YOY+14 -235Y+10 -2710Y+5 -35

3.3 Fundamental Score

Let's check the fundamental score of Biomerica Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.003
Price to Book Ratio (EOD)Between0-10.987
Net Profit Margin (MRQ)Greater than0-0.728
Operating Margin (MRQ)Greater than0-0.757
Quick Ratio (MRQ)Greater than12.032
Current Ratio (MRQ)Greater than12.996
Debt to Asset Ratio (MRQ)Less than10.321
Debt to Equity Ratio (MRQ)Less than10.472
Return on Equity (MRQ)Greater than0.15-0.246
Return on Assets (MRQ)Greater than0.05-0.167
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Biomerica Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.206
Ma 20Greater thanMa 500.332
Ma 50Greater thanMa 1000.336
Ma 100Greater thanMa 2000.342
OpenGreater thanClose0.297
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Biomerica Inc

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops, markets, and sells COVID-19 diagnostic tests to indicate if a person has been infected by COVID-19. The company was incorporated in 1971 and is headquartered in Irvine, California.

Fundamental data was last updated by Penke on 2024-12-05 14:25:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biomerica earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • A Net Profit Margin of -72.8% means that $-0.73 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biomerica Inc:

  • The MRQ is -72.8%. The company is making a huge loss. -2
  • The TTM is -121.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-72.8%TTM-121.2%+48.4%
TTM-121.2%YOY-121.5%+0.3%
TTM-121.2%5Y-92.2%-29.0%
5Y-92.2%10Y-59.5%-32.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-72.8%-6.4%-66.4%
TTM-121.2%-14.6%-106.6%
YOY-121.5%-16.4%-105.1%
5Y-92.2%-18.0%-74.2%
10Y-59.5%-21.7%-37.8%
4.3.1.2. Return on Assets

Shows how efficient Biomerica is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • -16.7% Return on Assets means that Biomerica generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biomerica Inc:

  • The MRQ is -16.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.7%TTM-15.8%-0.9%
TTM-15.8%YOY-14.4%-1.5%
TTM-15.8%5Y-12.2%-3.6%
5Y-12.2%10Y-9.3%-2.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.7%-2.2%-14.5%
TTM-15.8%-3.2%-12.6%
YOY-14.4%-4.1%-10.3%
5Y-12.2%-3.0%-9.2%
10Y-9.3%-4.0%-5.3%
4.3.1.3. Return on Equity

Shows how efficient Biomerica is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • -24.6% Return on Equity means Biomerica generated $-0.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biomerica Inc:

  • The MRQ is -24.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.6%TTM-21.7%-2.9%
TTM-21.7%YOY-19.0%-2.7%
TTM-21.7%5Y-16.8%-4.9%
5Y-16.8%10Y-12.3%-4.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.6%-2.6%-22.0%
TTM-21.7%-3.9%-17.8%
YOY-19.0%-4.7%-14.3%
5Y-16.8%-4.0%-12.8%
10Y-12.3%-5.5%-6.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biomerica Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biomerica is operating .

  • Measures how much profit Biomerica makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • An Operating Margin of -75.7% means the company generated $-0.76  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biomerica Inc:

  • The MRQ is -75.7%. The company is operating very inefficient. -2
  • The TTM is -125.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-75.7%TTM-125.4%+49.7%
TTM-125.4%YOY-124.6%-0.8%
TTM-125.4%5Y-93.7%-31.8%
5Y-93.7%10Y-59.4%-34.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.7%-13.1%-62.6%
TTM-125.4%-20.2%-105.2%
YOY-124.6%-13.7%-110.9%
5Y-93.7%-16.5%-77.2%
10Y-59.4%-20.9%-38.5%
4.3.2.2. Operating Ratio

Measures how efficient Biomerica is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.76 means that the operating costs are $1.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biomerica Inc:

  • The MRQ is 1.757. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.280. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.757TTM2.280-0.523
TTM2.280YOY2.246+0.033
TTM2.2805Y1.946+0.334
5Y1.94610Y1.601+0.345
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7571.213+0.544
TTM2.2801.305+0.975
YOY2.2461.328+0.918
5Y1.9461.366+0.580
10Y1.6011.312+0.289
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biomerica Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biomerica is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.00 means the company has $3.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biomerica Inc:

  • The MRQ is 2.996. The company is able to pay all its short-term debts. +1
  • The TTM is 4.145. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.996TTM4.145-1.149
TTM4.145YOY5.612-1.467
TTM4.1455Y5.193-1.048
5Y5.19310Y6.062-0.869
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9962.567+0.429
TTM4.1452.707+1.438
YOY5.6122.888+2.724
5Y5.1933.435+1.758
10Y6.0623.527+2.535
4.4.3.2. Quick Ratio

Measures if Biomerica is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • A Quick Ratio of 2.03 means the company can pay off $2.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biomerica Inc:

  • The MRQ is 2.032. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.023. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.032TTM3.023-0.991
TTM3.023YOY4.264-1.241
TTM3.0235Y3.612-0.589
5Y3.61210Y3.535+0.077
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0321.442+0.590
TTM3.0231.678+1.345
YOY4.2641.892+2.372
5Y3.6122.299+1.313
10Y3.5352.555+0.980
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biomerica Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biomerica assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biomerica to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.32 means that Biomerica assets are financed with 32.1% credit (debt) and the remaining percentage (100% - 32.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biomerica Inc:

  • The MRQ is 0.321. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.265. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.321TTM0.265+0.056
TTM0.265YOY0.229+0.037
TTM0.2655Y0.278-0.013
5Y0.27810Y0.211+0.067
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3210.401-0.080
TTM0.2650.401-0.136
YOY0.2290.362-0.133
5Y0.2780.431-0.153
10Y0.2110.453-0.242
4.5.4.2. Debt to Equity Ratio

Measures if Biomerica is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biomerica to the Medical Devices industry mean.
  • A Debt to Equity ratio of 47.2% means that company has $0.47 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biomerica Inc:

  • The MRQ is 0.472. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.365. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.472TTM0.365+0.107
TTM0.365YOY0.300+0.065
TTM0.3655Y0.414-0.049
5Y0.41410Y0.300+0.114
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4720.565-0.093
TTM0.3650.600-0.235
YOY0.3000.535-0.235
5Y0.4140.635-0.221
10Y0.3000.712-0.412
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biomerica generates.

  • Above 15 is considered overpriced but always compare Biomerica to the Medical Devices industry mean.
  • A PE ratio of -1.41 means the investor is paying $-1.41 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biomerica Inc:

  • The EOD is -1.003. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.406. Based on the earnings, the company is expensive. -2
  • The TTM is -2.099. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.003MRQ-1.406+0.403
MRQ-1.406TTM-2.099+0.693
TTM-2.099YOY-5.963+3.864
TTM-2.0995Y-20.581+18.482
5Y-20.58110Y-29.992+9.412
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.003-0.983-0.020
MRQ-1.406-1.351-0.055
TTM-2.099-1.807-0.292
YOY-5.963-2.342-3.621
5Y-20.581-2.144-18.437
10Y-29.992-1.958-28.034
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biomerica Inc:

  • The EOD is -0.982. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.377. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.767. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.982MRQ-1.377+0.395
MRQ-1.377TTM-2.767+1.390
TTM-2.767YOY-6.846+4.079
TTM-2.7675Y-569.090+566.324
5Y-569.09010Y-314.588-254.503
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.982-1.567+0.585
MRQ-1.377-1.910+0.533
TTM-2.767-2.233-0.534
YOY-6.846-5.489-1.357
5Y-569.090-4.008-565.082
10Y-314.588-4.828-309.760
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biomerica is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.38 means the investor is paying $1.38 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biomerica Inc:

  • The EOD is 0.987. Based on the equity, the company is cheap. +2
  • The MRQ is 1.384. Based on the equity, the company is underpriced. +1
  • The TTM is 1.790. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.987MRQ1.384-0.397
MRQ1.384TTM1.790-0.406
TTM1.790YOY4.909-3.118
TTM1.7905Y6.780-4.989
5Y6.78010Y7.783-1.003
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.9872.159-1.172
MRQ1.3842.159-0.775
TTM1.7902.344-0.554
YOY4.9093.005+1.904
5Y6.7804.023+2.757
10Y7.7834.497+3.286
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biomerica Inc.

4.8.1. Institutions holding Biomerica Inc

Institutions are holding 13.012% of the shares of Biomerica Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Granahan Investment Management Inc..3.13560.0068527461-332995-38.6998
2024-09-30Acadian Asset Management LLC1.34010.0001225435-685-0.3029
2024-09-30Vanguard Group Inc1.00470169010-45646-21.2647
2024-06-30BlackRock Inc0.8862014908100
2024-09-30Geode Capital Management, LLC0.73930124363-2143-1.694
2024-09-30UBS Group AG0.5451091692916920
2024-09-30Fore Capital, LLC0.35480.00825968000
2024-09-30State Street Corp0.221303723100
2024-09-30Susquehanna International Group, LLP0.205034489-67255-66.1022
2024-09-30Goss Wealth Management LLC0.1730.000129100-3600-11.0092
2024-06-30Jane Street Group LLC0.1664027986279860
2024-09-30Heritage Investors Management Corp0.1250.000221032-13566-39.2104
2024-09-30Northern Trust Corp0.122802066100
2024-09-30Penn Capital Management Company LLC0.12240.000620589-311-1.488
2024-09-30TWO SIGMA SECURITIES, LLC0.10070.000116941-1984-10.4835
2024-09-30Raymond James Finl Svs Advisors, Inc.0.086201450000
2024-09-30Hollencrest Securities, LLC0.0690.00021160000
2024-09-30Tower Research Capital LLC0.022903854-38-0.9764
2024-06-30Atlantic Trust Group, LLC0.01550260000
2024-06-30Bank of America Corp0.0088014791279639.5
Total 9.44480.01631588784-347266-21.9%

4.9.2. Funds holding Biomerica Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30JNL Multi-Manager Small Cap Growth A1.25870.003211736-172265-44.8606
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.00470.000116901000
2024-10-31Russell Inv Small Cap Fund B0.75990.008812782500
2024-09-30Fidelity Extended Market Index0.47770.00018035730723.9749
2024-06-30Perritt Ultra MicroCap0.41610.305870000700000
2024-09-30Granahan Small Cap Select0.39080.044865747-34753-34.5801
2024-09-30Victory Small Cap Stock0.39080.002465747-35178-34.8556
2024-09-30Granahan Inv Mgt Sm-Cap Core Gr0.39080.009965747-34753-34.5801
2024-09-30Fidelity Series Total Market Index0.117901983800
2024-09-30Fidelity Total Market Index0.081801375700
2024-09-30NT Ext Equity Mkt Idx Fd - L0.06160.00011036800
2024-09-30Northern Trust Extended Eq Market Idx0.06160.00011036800
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.04810809200
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.038806520200.3077
2024-09-30Fidelity Nasdaq Composite Index0.03480586000
2024-09-30Penn Capital Small to Micro Cap Equity0.03130.1248527200
2024-09-30Spartan Total Market Index Pool E0.02470416000
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00950.0001160030.1879
2024-10-31State St US Ttl Mkt Indx SL Cl I0.00710120000
2024-09-30Northern Trust Wilshire 50000.00680115000
Total 5.61350.5944354-203854-21.6%

5.3. Insider Transactions

Insiders are holding 7.215% of the shares of Biomerica Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-05-24Zackary S IraniBUY5001.61
2023-05-12Zackary S IraniBUY17001.17
2023-05-09Zackary S IraniBUY3001.39
2023-04-28Zackary S IraniBUY18001.34
2023-04-26Zackary S IraniBUY70001.26
2023-01-27Allen BarbieriBUY15382.94
2023-01-26Catherine CosteBUY21902.96
2023-01-24Zackary S IraniBUY20002.81
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-08-31. Currency in USD. All numbers in thousands.

Summary
Total Assets7,870
Total Liabilities2,524
Total Stockholder Equity5,346
 As reported
Total Liabilities 2,524
Total Stockholder Equity+ 5,346
Total Assets = 7,870

Assets

Total Assets7,870
Total Current Assets6,445
Long-term Assets1,425
Total Current Assets
Cash And Cash Equivalents 2,820
Net Receivables 1,551
Inventory 1,942
Other Current Assets 132
Total Current Assets  (as reported)6,445
Total Current Assets  (calculated)6,445
+/-0
Long-term Assets
Property Plant Equipment 850
Long Term Investments 165
Intangible Assets 207
Long-term Assets Other 203
Long-term Assets  (as reported)1,425
Long-term Assets  (calculated)1,425
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,151
Long-term Liabilities373
Total Stockholder Equity5,346
Total Current Liabilities
Short-term Debt 668
Accounts payable 1,089
Other Current Liabilities 309
Total Current Liabilities  (as reported)2,151
Total Current Liabilities  (calculated)2,066
+/- 85
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt39
Long-term Liabilities  (as reported)373
Long-term Liabilities  (calculated)39
+/- 334
Total Stockholder Equity
Common Stock1,346
Retained Earnings -49,511
Accumulated Other Comprehensive Income -108
Other Stockholders Equity 53,619
Total Stockholder Equity (as reported)5,346
Total Stockholder Equity (calculated)5,346
+/-0
Other
Capital Stock1,346
Cash and Short Term Investments 2,820
Common Stock Shares Outstanding 16,822
Current Deferred Revenue85
Liabilities and Stockholders Equity 7,870
Net Debt -2,113
Net Invested Capital 5,346
Net Working Capital 4,294
Property Plant and Equipment Gross 1,836
Short Long Term Debt Total 707



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-08-312024-05-312024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302012-08-312012-05-312012-02-292011-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302009-08-312009-05-312009-02-282008-11-302008-08-312008-05-312008-02-292007-11-302007-08-312007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312005-05-312005-02-282004-11-302004-08-312004-05-312004-02-292003-11-302003-08-312003-05-312003-02-282002-11-302002-08-312002-05-312002-02-282001-11-302001-08-312001-05-312001-02-282000-11-302000-08-312000-05-312000-02-291999-11-301999-08-311999-05-311999-02-281998-11-301998-08-311998-05-311998-02-281997-11-301997-08-311997-05-311997-02-281996-11-301996-08-311996-05-311996-02-291995-11-301995-08-311995-05-311995-02-281994-11-301994-08-311994-05-311994-02-281993-11-301993-08-311993-05-311993-02-281992-11-301992-08-311992-05-311992-02-291991-11-301991-08-311991-05-311991-02-281990-11-301990-08-311990-05-311990-02-281989-11-301989-08-311989-05-311989-02-281988-11-301988-08-311988-05-311988-02-291987-11-301987-08-311987-05-311987-02-281986-11-301986-08-311986-05-311986-02-281985-11-301985-08-31
> Total Assets 
0
0
0
7,500
0
0
0
6,300
0
0
0
4,800
0
0
4,400
3,800
4,100
0
3,300
9,000
8,700
8,500
7,900
7,300
7,200
7,000
6,700
6,400
6,300
6,500
6,300
6,300
5,900
5,900
6,100
6,300
5,900
5,700
5,600
5,800
5,700
5,700
5,900
6,100
6,300
6,300
7,500
7,400
7,500
7,700
7,600
7,500
7,500
7,500
7,400
7,800
7,800
8,800
7,905
6,735
6,735
6,358
6,102
5,347
5,347
5,201
5,360
5,277
4,914
4,997
5,113
5,113
5,548
5,254
5,541
5,568
5,568
5,817
5,840
5,791
5,791
6,682
2,346
2,428
2,549
2,659
2,807
3,225
3,963
4,078
4,132
5,108
5,154
5,041
5,274
5,152
5,163
4,910
5,119
5,015
4,873
4,784
4,858
4,955
4,971
5,075
5,544
5,571
5,980
6,058
6,111
6,395
6,205
5,827
6,271
6,470
6,047
5,928
5,832
6,124
6,075
5,942
5,876
5,727
5,610
5,585
5,477
5,018
4,913
4,831
4,759
5,223
4,876
5,429
5,068
5,245
6,724
7,039
8,215
17,260
15,892
14,478
13,348
11,819
11,516
14,809
17,560
11,374
11,050
9,908
8,210
14,454
13,219
11,831
10,342
9,254
7,870
7,8709,25410,34211,83113,21914,4548,2109,90811,05011,37417,56014,80911,51611,81913,34814,47815,89217,2608,2157,0396,7245,2455,0685,4294,8765,2234,7594,8314,9135,0185,4775,5855,6105,7275,8765,9426,0756,1245,8325,9286,0476,4706,2715,8276,2056,3956,1116,0585,9805,5715,5445,0754,9714,9554,8584,7844,8735,0155,1194,9105,1635,1525,2745,0415,1545,1084,1324,0783,9633,2252,8072,6592,5492,4282,3466,6825,7915,7915,8405,8175,5685,5685,5415,2545,5485,1135,1134,9974,9145,2775,3605,2015,3475,3476,1026,3586,7356,7357,9058,8007,8007,8007,4007,5007,5007,5007,6007,7007,5007,4007,5006,3006,3006,1005,9005,7005,7005,8005,6005,7005,9006,3006,1005,9005,9006,3006,3006,5006,3006,4006,7007,0007,2007,3007,9008,5008,7009,0003,30004,1003,8004,400004,8000006,3000007,500000
   > Total Current Assets 
0
0
0
7,100
0
0
0
5,700
0
0
0
4,400
0
0
2,100
1,600
1,900
0
1,100
5,900
5,700
5,400
4,900
4,800
4,800
4,700
4,600
4,600
4,500
4,800
4,700
4,500
4,200
4,300
4,100
4,800
4,400
4,200
4,200
4,500
4,400
4,500
4,700
4,900
5,300
5,300
6,500
6,300
6,400
6,700
6,500
6,500
6,500
6,500
6,400
6,800
6,800
7,800
6,966
5,809
5,809
5,429
5,202
4,677
4,677
4,622
4,818
4,882
4,552
4,590
4,707
4,707
5,023
4,521
4,752
4,750
4,750
4,953
4,955
4,287
4,287
4,690
2,193
1,846
1,913
2,044
2,213
2,610
3,314
3,377
3,262
4,538
4,562
4,440
4,699
4,555
4,537
3,998
4,183
4,093
3,948
3,777
3,857
3,886
3,879
4,014
4,414
4,487
4,885
4,842
4,938
5,253
5,105
4,699
5,061
4,913
4,538
4,467
4,431
4,466
4,464
4,158
3,981
4,835
4,769
4,772
4,644
4,210
4,171
4,099
4,049
4,484
4,117
4,688
4,329
4,495
4,114
4,511
5,739
14,767
13,120
11,947
10,785
9,231
8,946
12,403
15,231
9,428
9,168
8,099
6,482
12,797
11,574
10,265
8,846
7,731
6,445
6,4457,7318,84610,26511,57412,7976,4828,0999,1689,42815,23112,4038,9469,23110,78511,94713,12014,7675,7394,5114,1144,4954,3294,6884,1174,4844,0494,0994,1714,2104,6444,7724,7694,8353,9814,1584,4644,4664,4314,4674,5384,9135,0614,6995,1055,2534,9384,8424,8854,4874,4144,0143,8793,8863,8573,7773,9484,0934,1833,9984,5374,5554,6994,4404,5624,5383,2623,3773,3142,6102,2132,0441,9131,8462,1934,6904,2874,2874,9554,9534,7504,7504,7524,5215,0234,7074,7074,5904,5524,8824,8184,6224,6774,6775,2025,4295,8095,8096,9667,8006,8006,8006,4006,5006,5006,5006,5006,7006,4006,3006,5005,3005,3004,9004,7004,5004,4004,5004,2004,2004,4004,8004,1004,3004,2004,5004,7004,8004,5004,6004,6004,7004,8004,8004,9005,4005,7005,9001,10001,9001,6002,100004,4000005,7000007,100000
       Cash And Cash Equivalents 
0
0
0
6,200
0
0
0
4,700
0
0
0
3,700
0
0
0
0
0
0
0
0
0
100
200
200
100
100
200
300
500
500
200
300
400
600
400
800
600
600
800
700
400
400
600
600
1,000
900
1,900
1,700
1,800
1,800
1,800
1,800
1,800
1,800
1,700
1,700
1,700
2,600
1,648
634
634
247
234
136
136
54
119
329
271
490
580
580
525
297
179
352
352
223
221
352
352
150
47
120
90
38
66
517
991
808
822
2,022
1,961
1,788
1,529
1,596
1,692
1,403
1,130
1,055
813
972
904
989
1,021
966
898
1,077
1,299
1,194
2,319
2,470
2,085
1,648
1,666
1,509
1,647
1,674
1,172
1,088
893
643
859
1,889
1,817
1,611
1,542
1,225
1,081
818
597
1,205
584
1,125
918
687
808
851
2,392
8,641
6,964
5,684
5,273
4,199
4,997
7,199
10,174
5,917
6,075
5,067
3,345
9,719
7,988
7,134
5,319
4,170
2,820
2,8204,1705,3197,1347,9889,7193,3455,0676,0755,91710,1747,1994,9974,1995,2735,6846,9648,6412,3928518086879181,1255841,2055978181,0811,2251,5421,6111,8171,8898596438931,0881,1721,6741,6471,5091,6661,6482,0852,4702,3191,1941,2991,0778989661,0219899049728131,0551,1301,4031,6921,5961,5291,7881,9612,02282280899151766389012047150352352221223352352179297525580580490271329119541361362342476346341,6482,6001,7001,7001,7001,8001,8001,8001,8001,8001,8001,7001,9009001,0006006004004007008006006008004006004003002005005003002001001002002001000000000003,7000004,7000006,200000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
98
99
99
84
55
42
42
13
1
3
1
1
0
0
13
35
34
26
26
19
13
8
8
4
400
3
3
2
1
1
1
1
0
0
0
1
101
100
100
0
0
0
0
0
0
165,324
165,324
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
165
165
0
0
165
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001650016516500000000000000000000000000000000000165,324165,324000000100100101100011112334004881319262634351300113113424255849999981001001000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
400
0
0
0
300
0
0
0
200
0
0
300
200
400
0
200
2,500
2,200
2,100
2,000
2,000
1,700
1,600
1,300
1,300
1,400
1,300
1,300
1,500
1,500
1,500
1,500
1,500
1,500
1,600
1,600
1,600
1,700
1,500
1,400
1,800
1,700
1,700
1,900
1,500
1,500
1,900
1,800
1,600
1,600
1,500
1,500
1,600
1,600
1,500
1,451
1,702
1,702
1,675
1,445
1,544
1,544
1,505
1,661
1,507
1,279
1,285
1,541
1,541
1,663
1,357
1,750
1,517
1,517
1,579
1,760
1,722
1,722
2,050
533
561
574
740
677
505
742
664
666
614
524
576
830
641
540
539
977
1,018
1,040
875
993
747
865
1,132
1,343
1,201
1,373
1,510
513
872
903
822
1,172
1,448
788
564
931
1,112
1,214
1,173
920
969
969
1,141
1,072
1,060
1,047
1,055
1,158
800
1,014
1,261
1,077
1,455
859
1,283
962
1,766
1,583
1,612
1,878
1,455
772
1,125
1,159
774
932
850
755
722
1,430
1,067
1,130
947
1,551
1,5519471,1301,0671,4307227558509327741,1591,1257721,4551,8781,6121,5831,7669621,2838591,4551,0771,2611,0148001,1581,0551,0471,0601,0721,1419699699201,1731,2141,1129315647881,4481,1728229038725131,5101,3731,2011,3431,1328657479938751,0401,0189775395406418305765246146666647425056777405745615332,0501,7221,7221,7601,5791,5171,5171,7501,3571,6631,5411,5411,2851,2791,5071,6611,5051,5441,5441,4451,6751,7021,7021,4511,5001,6001,6001,5001,5001,6001,6001,8001,9001,5001,5001,9001,7001,7001,8001,4001,5001,7001,6001,6001,6001,5001,5001,5001,5001,5001,5001,3001,3001,4001,3001,3001,6001,7002,0002,0002,1002,2002,500200040020030000200000300000400000
       Other Current Assets 
0
0
0
200
0
0
0
100
0
0
0
100
0
0
1,400
1,000
1,200
0
600
600
500
500
500
400
600
500
700
700
200
500
700
500
400
400
500
900
700
500
400
400
300
500
600
400
400
400
400
700
500
500
500
0
600
300
200
300
300
500
542
479
514
473
391
89
89
96
113
122
143
118
81
81
171
176
152
182
182
217
3
115
115
134
5
58
1
1
1
126
1
1
1
137
122
82
158
219
247
107
118
230
219
0
124
365
1,112
246
310
388
391
338
401
341
325
330
285
191
222
239
217
238
248
105
102
114
132
139
212
196
251
400
341
300
0
187
254
202
242
0
198
1,509
0
0
0
0
0
0
0
0
0
0
319
300
279
446
268
238
132
13223826844627930031900000000001,509198024220225418703003414002511962121391321141021052482382172392221912853303253414013383913883102461,11236512402192301181072472191588212213711112611158513411511532171821821521761718181118143122113968989391473514479542500300300200300600050050050070040040040040060050030040040050070090050040040050070050020070070050060040050050050060060001,2001,0001,40000100000100000200000
   > Long-term Assets 
0
0
0
400
0
0
0
600
0
0
0
400
0
0
2,300
2,200
2,200
0
2,200
3,100
3,000
3,100
3,000
2,500
2,400
2,300
2,100
1,800
1,800
1,700
1,600
1,800
1,700
1,600
2,000
1,500
1,500
1,500
1,400
1,300
1,300
1,200
1,200
1,200
1,000
1,000
1,000
1,100
1,100
1,000
1,100
0
1,000
1,000
1,000
1,000
1,000
1,000
939
927
927
929
900
670
670
580
542
395
362
407
406
406
525
733
789
818
818
864
885
1,504
1,504
1,992
153
582
636
615
593
614
649
701
870
570
591
601
574
597
626
912
936
922
925
1,007
1,001
1,069
1,093
1,061
1,130
1,084
1,095
1,216
1,172
1,142
1,100
1,128
1,210
1,557
1,510
1,461
1,401
1,659
1,611
1,784
1,895
891
842
813
833
808
742
732
710
739
759
741
739
750
2,610
2,528
2,476
2,493
2,772
2,531
2,563
2,588
2,570
2,406
2,329
1,946
1,882
1,809
1,728
1,657
1,645
1,566
1,496
1,523
1,425
1,4251,5231,4961,5661,6451,6571,7281,8091,8821,9462,3292,4062,5702,5882,5632,5312,7722,4932,4762,5282,6107507397417597397107327428088338138428911,8951,7841,6111,6591,4011,4611,5101,5571,2101,1281,1001,1421,1721,2161,0951,0841,1301,0611,0931,0691,0011,0079259229369126265975746015915708707016496145936156365821531,9921,5041,5048858648188187897335254064064073623955425806706709009299279279391,0001,0001,0001,0001,0001,00001,1001,0001,1001,1001,0001,0001,0001,2001,2001,2001,3001,3001,4001,5001,5001,5002,0001,6001,7001,8001,6001,7001,8001,8002,1002,3002,4002,5003,0003,1003,0003,1002,20002,2002,2002,30000400000600000400000
       Property Plant Equipment 
0
0
0
300
0
0
0
300
0
0
0
200
0
0
200
100
100
0
100
1,300
1,300
1,400
1,300
1,300
1,200
1,100
1,000
1,000
900
800
800
800
700
700
600
500
500
500
600
500
500
500
500
500
400
400
400
500
500
500
500
500
500
400
400
400
400
500
471
470
470
513
497
318
318
266
247
228
214
255
265
265
387
593
659
717
717
766
790
817
817
1,919
123
127
182
190
180
168
160
179
350
370
381
387
381
367
368
566
573
562
538
562
547
567
571
545
597
585
605
734
692
655
621
652
640
614
572
532
485
445
411
395
398
381
344
332
368
332
321
326
319
351
362
349
346
351
2,202
2,127
2,069
1,991
1,946
1,885
1,845
1,864
1,778
1,701
1,631
1,515
1,463
1,406
1,329
1,248
1,182
1,101
1,011
943
850
8509431,0111,1011,1821,2481,3291,4061,4631,5151,6311,7011,7781,8641,8451,8851,9461,9912,0692,1272,2023513463493623513193263213323683323443813983954114454855325726146406526216556927346055855975455715675475625385625735663683673813873813703501791601681801901821271231,9198178177907667177176595933872652652552142282472663183184975134704704715004004004004005005005005005005004004004005005005005005006005005005006007007008008008009001,0001,0001,1001,2001,3001,3001,4001,3001,300100010010020000200000300000300000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
498
499
0
0
0
0
0
0
0
0
0
0
00000000004994980000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
165
16516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516516500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
1,500
1,400
1,400
1,200
1,200
1,100
1,100
900
900
900
800
800
800
800
800
700
700
700
700
600
600
600
600
600
500
500
500
500
500
500
400
500
500
500
500
400
400
400
390
367
367
342
321
297
297
262
239
116
97
99
85
85
70
51
41
49
49
17
15
13
13
10
9
8
6
5
4
3
1
0
0
0
0
0
0
30
33
34
45
84
107
139
158
177
195
187
203
195
186
177
173
165
158
154
248
382
370
360
340
321
304
285
265
249
233
212
193
174
157
139
122
99
105
98
95
107
114
110
114
169
216
218
269
295
360
-109
-113
170
161
158
155
165
202
204
216
212
207
207212216204202165155158161170-113-1093602952692182161691141101141079598105991221391571741932122332492652853043213403603703822481541581651731771861952031871951771581391078445343330000000134568910131315174949415170858599971162392622972973213423673673904004004005005005005004005005005005005005006006006006006007007007007008008008008008009009009001,1001,1001,2001,2001,4001,4001,5001,5000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
468
456
437
416
403
352
317
313
296
167
148
152
141
138
143
140
129
101
105
98
95
687
685
674
30
455
454
425
414
447
489
522
520
200
210
214
193
230
258
346
363
360
388
445
454
502
521
516
533
499
490
482
480
487
479
475
570
942
937
929
915
1,213
1,200
1,389
1,497
511
498
481
465
476
421
405
391
123
127
130
132
127
129
125
128
168
445
2,024
283
264
267
150
147
0
94
80
79
79
96
0
0
0
0
0000967979809401471502672642832,0244451681281251291271321301271233914054214764654814985111,4971,3891,2001,2139159299379425704754794874804824904995335165215024544453883603633462582301932142102005205224894474144254544553067468568795981051011291401431381411521481672963133173524034164374564680000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85
85
359
359
359
359
670
670
873
998
41
41
0
0
41
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000041004141998873670670359359359359858500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
1,400
0
0
0
1,700
0
0
0
700
0
0
600
500
800
0
500
4,400
4,200
4,400
4,400
4,800
4,800
4,800
4,600
4,100
4,100
3,600
3,500
3,500
3,100
3,200
2,800
3,000
2,700
2,500
2,400
2,600
2,300
2,000
2,200
2,000
2,000
2,000
2,000
1,500
1,500
1,700
1,500
1,300
1,300
1,500
1,500
1,600
1,600
1,700
1,752
1,828
1,828
2,319
2,020
1,827
1,827
2,082
2,185
1,981
1,693
1,894
1,974
1,974
2,302
2,297
2,460
2,054
2,054
2,475
2,443
2,258
2,258
2,832
1,493
1,365
1,395
1,421
1,452
1,472
1,266
1,313
1,201
1,224
1,095
1,068
1,012
804
804
832
896
952
823
722
715
625
524
422
663
592
710
546
584
560
537
401
543
556
349
467
483
524
539
469
487
506
445
567
657
529
627
804
759
897
798
1,017
1,113
1,264
3,100
3,663
3,534
3,047
3,312
3,329
2,748
2,592
2,713
5,908
7,803
3,050
2,728
2,665
2,224
2,730
2,451
2,448
2,534
2,663
2,524
2,5242,6632,5342,4482,4512,7302,2242,6652,7283,0507,8035,9082,7132,5922,7483,3293,3123,0473,5343,6633,1001,2641,1131,0177988977598046275296575674455064874695395244834673495565434015375605845467105926634225246257157228239528968328048041,0121,0681,0951,2241,2011,3131,2661,4721,4521,4211,3951,3651,4932,8322,2582,2582,4432,4752,0542,0542,4602,2972,3021,9741,9741,8941,6931,9812,1852,0821,8271,8272,0202,3191,8281,8281,7521,7001,6001,6001,5001,5001,3001,3001,5001,7001,5001,5002,0002,0002,0002,0002,2002,0002,3002,6002,4002,5002,7003,0002,8003,2003,1003,5003,5003,6004,1004,1004,6004,8004,8004,8004,4004,4004,2004,4005000800500600007000001,7000001,400000
   > Total Current Liabilities 
0
0
0
1,200
0
0
0
1,500
0
0
0
500
0
0
600
500
800
0
600
3,200
3,200
3,400
4,100
4,800
4,700
4,700
4,500
4,100
4,000
3,500
3,400
3,400
3,100
3,200
2,900
3,100
2,700
1,500
1,400
1,600
1,500
1,600
1,800
1,700
1,800
1,900
1,900
1,500
1,500
1,700
1,500
1,400
1,400
1,400
1,500
1,600
1,600
1,600
1,752
1,828
1,828
2,319
2,020
1,732
1,732
1,822
1,875
1,636
1,355
1,894
1,974
1,974
2,048
2,060
2,383
2,054
2,054
2,475
2,443
2,258
2,258
2,569
1,493
1,356
1,387
1,415
1,447
1,412
1,202
1,175
1,072
1,109
994
980
922
724
735
733
787
917
799
710
644
625
524
422
663
592
710
546
584
560
537
401
543
556
349
467
483
524
539
469
487
506
445
567
657
529
627
804
759
897
798
1,017
1,113
1,264
1,369
1,984
1,910
1,477
1,801
1,874
1,352
1,300
1,482
4,741
6,698
2,011
1,758
1,763
1,395
1,945
1,746
1,822
1,991
2,204
2,151
2,1512,2041,9911,8221,7461,9451,3951,7631,7582,0116,6984,7411,4821,3001,3521,8741,8011,4771,9101,9841,3691,2641,1131,0177988977598046275296575674455064874695395244834673495565434015375605845467105926634225246256447107999177877337357249229809941,1091,0721,1751,2021,4121,4471,4151,3871,3561,4932,5692,2582,2582,4432,4752,0542,0542,3832,0602,0481,9741,9741,8941,3551,6361,8751,8221,7321,7322,0202,3191,8281,8281,7521,6001,6001,6001,5001,4001,4001,4001,5001,7001,5001,5001,9001,9001,8001,7001,8001,6001,5001,6001,4001,5002,7003,1002,9003,2003,1003,4003,4003,5004,0004,1004,5004,7004,7004,8004,1003,4003,2003,2006000800500600005000001,5000001,200000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,600
1,400
1,500
2,400
2,600
2,700
2,700
2,400
2,200
2,200
2,000
2,000
2,200
2,100
2,000
1,900
1,800
1,600
300
300
400
400
400
400
500
500
300
300
400
300
300
200
100
100
200
200
200
200
200
220
160
160
723
263
140
140
173
117
96
1
0
329
329
59
86
25
317
317
467
513
476
476
586
268
265
253
246
238
172
158
188
180
100
53
2
44
0
43
44
44
45
46
47
47
35
24
12
0
43
43
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
195
200
206
212
221
224
229
328
333
335
339
341
344
347
349
297
306
622
638
326
668
668326638622306297349347344341339335333328229224221212206200195000000000000000000000000000434301224354747464544444304425310018018815817223824625326526858647647651346731731725865932932901961171731401402637231601602202002002002002001001002003003004003003005005004004004004003003001,6001,8001,9002,0002,1002,2002,0002,0002,2002,2002,4002,7002,7002,6002,4001,5001,4001,6000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
400
300
0
200
1,600
1,800
1,800
1,600
1,400
2,000
2,000
1,800
1,500
1,800
1,500
1,300
700
600
800
600
600
500
500
400
600
500
700
600
700
700
600
800
700
700
900
900
0
800
900
900
1,000
1,000
1,100
1,265
1,314
1,314
1,142
1,150
931
931
980
1,069
906
743
860
956
956
1,280
1,115
1,205
983
983
1,136
1,110
1,083
1,083
1,282
678
581
634
702
721
666
572
564
402
474
469
479
402
264
304
345
422
402
480
306
275
246
500
163
452
188
338
226
195
282
216
168
317
386
178
250
312
357
375
293
312
326
263
367
483
336
419
586
534
656
548
765
853
1,000
944
1,345
1,268
987
1,271
1,258
756
432
641
1,581
2,609
736
671
670
387
344
713
783
885
288
1,089
1,0892888857837133443876706717362,6091,5816414327561,2581,2719871,2681,3459441,0008537655486565345864193364833672633263122933753573122501783863171682162821952263381884521635002462753064804024223453042644024794694744025645726667217026345816781,2821,0831,0831,1101,1369839831,2051,1151,2809569568607439061,0699809319311,1501,1421,3141,3141,2651,1001,0001,00090090080009009007007008006007007006007005006004005005006006008006007001,3001,5001,8001,5001,8002,0002,0001,4001,6001,8001,8001,600200030040030000000000000000
       Other Current Liabilities 
0
0
0
1,200
0
0
0
1,500
0
0
0
500
0
0
300
100
500
0
400
0
0
100
100
800
0
0
300
400
0
0
100
500
400
400
400
700
600
700
700
600
600
500
800
500
600
1,000
800
400
500
500
400
0
500
300
400
400
400
300
266
353
354
454
606
661
398
669
374
326
348
1,034
364
689
708
367
681
754
288
272
272
699
105
105
105
27
501
467
487
5
472
424
491
536
472
51
476
724
692
690
743
872
754
664
597
343
500
410
211
302
372
320
390
278
321
233
226
170
171
217
172
167
164
176
175
180
182
199
174
192
208
219
225
241
249
252
260
265
230
200
200
279
309
392
367
541
508
674
537
883
592
697
520
1,244
667
654
681
1,505
309
3091,5056816546671,244520697592883537674508541367392309279200200230265260252249241225219208192174199182180175176164167172217171170226233321278390320372302211410500343597664754872743690692724476514725364914244725487467501271051051056992722722887546813677086893641,03434832637466939866160645435435326630040040040030050004005005004008001,0006005008005006006007007006007004004004005001000040030000800100100004000500100300005000001,5000001,200000
   > Long-term Liabilities 
0
0
0
200
0
0
0
200
0
0
0
200
0
0
0
0
0
0
-100
1,200
1,000
1,000
300
100
100
100
100
100
100
100
100
100
0
0
-100
-100
0
1,000
1,000
1,000
800
400
400
300
200
100
100
0
0
0
0
0
-100
100
0
0
100
100
0
0
0
0
0
95
95
260
310
345
338
0
0
255
255
237
77
0
0
0
0
0
0
263
0
9
8
7
6
60
65
138
128
115
102
88
90
81
70
99
109
35
24
12
72
451,569
451,569
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,731
1,678
1,624
1,570
1,510
1,455
1,396
1,292
1,231
1,167
1,105
1,038
971
901
829
785
705
626
543
459
373
3734595436267057858299019711,0381,1051,1671,2311,2921,3961,4551,5101,5701,6241,6781,7310000000000000000000000000000000451,569451,569721224351099970819088102115128138656067890263000000772372552550033834531026095950000010010000100-100000001001002003004004008001,0001,0001,0000-100-100001001001001001001001001001003001,0001,0001,200-100000000200000200000200000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85
85
359
359
359
359
670
670
873
998
41
41
0
0
41
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000041004141998873670670359359359359858500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41
63
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000063410000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
6,100
0
0
0
4,600
0
0
0
4,100
0
0
3,700
3,300
3,300
0
2,800
2,800
2,700
2,700
2,400
1,800
1,700
1,600
1,400
1,300
1,200
1,200
1,000
1,200
1,100
1,100
1,600
1,600
1,500
1,400
1,400
1,400
1,500
1,700
1,800
2,000
2,200
2,200
3,400
3,600
3,700
3,700
3,800
0
3,700
3,600
3,500
6,200
3,800
4,900
4,011
2,796
2,796
2,032
2,059
1,473
1,473
1,111
1,132
1,211
1,133
990
1,005
1,005
1,100
898
975
926
926
795
850
1,053
1,053
1,057
854
1,064
1,154
1,237
1,355
1,753
2,696
2,765
2,931
3,884
4,058
3,973
4,261
4,348
4,359
4,078
4,222
4,063
4,050
4,062
4,142
4,330
4,448
4,653
4,882
4,979
5,270
5,513
5,526
5,835
5,669
5,427
5,728
5,914
5,698
5,461
5,348
5,601
5,536
5,473
5,389
5,220
5,165
5,019
4,820
4,489
4,287
4,027
4,000
4,326
4,078
4,412
3,954
3,981
3,624
3,376
4,681
14,213
12,581
11,149
10,600
9,227
8,803
8,901
9,758
8,325
8,322
7,243
5,986
11,724
10,768
9,383
7,808
6,591
5,346
5,3466,5917,8089,38310,76811,7245,9867,2438,3228,3259,7588,9018,8039,22710,60011,14912,58114,2134,6813,3763,6243,9813,9544,4124,0784,3264,0004,0274,2874,4894,8205,0195,1655,2205,3895,4735,5365,6015,3485,4615,6985,9145,7285,4275,6695,8355,5265,5135,2704,9794,8824,6534,4484,3304,1424,0624,0504,0634,2224,0784,3594,3484,2613,9734,0583,8842,9312,7652,6961,7531,3551,2371,1541,0648541,0571,0531,0538507959269269758981,1001,0051,0059901,1331,2111,1321,1111,4731,4732,0592,0322,7962,7964,0114,9003,800